Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial.

de Jonghe A, van Munster BC, van Oosten HE, Goslings JC, Kloen P, van Rees C, Wolvius R, van Velde R, Levi MM, Korevaar JC, de Rooij SE; Amsterdam Delirium Study group.

BMC Geriatr. 2011 Jul 5;11:34. doi: 10.1186/1471-2318-11-34.

2.

Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial.

Schrijver EJ, de Vries OJ, Verburg A, de Graaf K, Bet PM, van de Ven PM, Kamper AM, Diepeveen SH, Anten S, Siegel A, Kuipéri E, Lagaay AM, van Marum RJ, van Strien AM, Boelaarts L, Pons D, Kramer MH, Nanayakkara PW.

BMC Geriatr. 2014 Aug 28;14:96. doi: 10.1186/1471-2318-14-96.

3.

Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial.

de Jonghe A, van Munster BC, Goslings JC, Kloen P, van Rees C, Wolvius R, van Velde R, Levi M, de Haan RJ, de Rooij SE; Amsterdam Delirium Study Group.

CMAJ. 2014 Oct 7;186(14):E547-56. doi: 10.1503/cmaj.140495. Epub 2014 Sep 2.

5.

Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.

Martinez FE, Anstey M, Ford A, Roberts B, Hardie M, Palmer R, Choo L, Hillman D, Hensley M, Kelty E, Murray K, Singh B, Wibrow B.

Trials. 2017 Jan 6;18(1):4. doi: 10.1186/s13063-016-1751-0.

6.

The Healthy Heart-Mind trial: melatonin for prevention of delirium following cardiac surgery: study protocol for a randomized controlled trial.

Ford AH, Flicker L, Passage J, Wibrow B, Anstey M, Edwards M, Almeida OP.

Trials. 2016 Jan 28;17:55. doi: 10.1186/s13063-016-1163-1.

7.

The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial).

Watne LO, Torbergsen AC, Conroy S, Engedal K, Frihagen F, Hjorthaug GA, Juliebo V, Raeder J, Saltvedt I, Skovlund E, Wyller TB.

BMC Med. 2014 Apr 15;12:63. doi: 10.1186/1741-7015-12-63.

8.

[Delirium, insomnia in hospitalization and ramelteon].

Ito T.

Nihon Rinsho. 2012 May;70(5):907-13. Japanese.

PMID:
22620020
9.

The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial.

Bush SH, Lacaze-Masmonteil N, McNamara-Kilian MT, MacDonald AR, Tierney S, Momoli F, Agar M, Currow DC, Lawlor PG.

Trials. 2016 Aug 11;17:399. doi: 10.1186/s13063-016-1525-8.

10.

Reducing delirium after hip fracture: a randomized trial.

Marcantonio ER, Flacker JM, Wright RJ, Resnick NM.

J Am Geriatr Soc. 2001 May;49(5):516-22.

PMID:
11380742
11.

Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study.

Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P, van Gool WA.

J Am Geriatr Soc. 2005 Oct;53(10):1658-66.

PMID:
16181163
12.

The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial.

Neerland BE, Hov KR, Bruun Wyller V, Qvigstad E, Skovlund E, MacLullich AM, Bruun Wyller T.

BMC Geriatr. 2015 Feb 10;15:7. doi: 10.1186/s12877-015-0006-3.

13.

Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study.

Burry L, Scales D, Williamson D, Foster J, Mehta S, Guenette M, Fan E, Detsky M, Azad A, Bernard F, Rose L.

BMJ Open. 2017 Mar 30;7(3):e015420. doi: 10.1136/bmjopen-2016-015420.

14.

Delirium is independently associated with poor functional recovery after hip fracture.

Marcantonio ER, Flacker JM, Michaels M, Resnick NM.

J Am Geriatr Soc. 2000 Jun;48(6):618-24.

PMID:
10855596
15.

Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.

Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, Jackson J, Perkins GD, McAuley DF.

Lancet Respir Med. 2013 Sep;1(7):515-23. doi: 10.1016/S2213-2600(13)70166-8. Epub 2013 Aug 21. Erratum in: Lancet Respir Med. 2013 Oct;1(8):592.

16.

Delirium risk screening and haloperidol prophylaxis program in hip fracture patients is a helpful tool in identifying high-risk patients, but does not reduce the incidence of delirium.

Vochteloo AJ, Moerman S, van der Burg BL, de Boo M, de Vries MR, Niesten DD, Tuinebreijer WE, Nelissen RG, Pilot P.

BMC Geriatr. 2011 Aug 11;11:39. doi: 10.1186/1471-2318-11-39.

17.

Delirium is a risk factor for institutionalization and functional decline in older hip fracture patients.

Krogseth M, Wyller TB, Engedal K, Juliebø V.

J Psychosom Res. 2014 Jan;76(1):68-74. doi: 10.1016/j.jpsychores.2013.10.006. Epub 2013 Oct 16.

PMID:
24360144
18.

Estimating the effect of incident delirium on short-term outcomes in aged hip fracture patients through propensity score analysis.

Radinovic K, Markovic-Denic L, Dubljanin-Raspopovic E, Marinkovic J, Milan Z, Bumbasirevic V.

Geriatr Gerontol Int. 2015 Jul;15(7):848-55. doi: 10.1111/ggi.12358. Epub 2014 Sep 26.

PMID:
25258087
19.

Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients: a multi-centre double-blind randomised controlled clinical trial.

Schrijver EJM, de Vries OJ, van de Ven PM, Bet PM, Kamper AM, Diepeveen SHA, van Marum RJ, van Strien AM, Anten S, Lagaay AM, Boelaarts L, Bloemers FW, Kramer MHH, Nanayakkara PWB.

Age Ageing. 2018 Jan 1;47(1):48-55. doi: 10.1093/ageing/afx124.

PMID:
28985255
20.

Impact of oral melatonin on critically ill adult patients with ICU sleep deprivation: study protocol for a randomized controlled trial.

Huang H, Jiang L, Shen L, Zhang G, Zhu B, Cheng J, Xi X.

Trials. 2014 Aug 18;15:327. doi: 10.1186/1745-6215-15-327.

Supplemental Content

Support Center